New research found no pharmacological differences between natural and synthetic cannabidiol (CBD).
A new study published in the journal, Medical Cannabis and Cannabinoids, revealed that both naturally purified and synthetic CBD were equally effective in repairing cell damage, preventing cancer cell growth, and reducing inflammation under laboratory tests.
The research was conducted by the University of Nottingham in collaboration with American clinical-stage biopharmaceutical company, Artelo Biosciences.
“There is no pharmacological difference between purified natural and synthetic CBD in vitro,” the study authors said.
CBD has gained medical attention in recent years for its anti-pain, anti-cancer, and anti-inflammatory effects.